Stock Price
4.17
Daily Change
0.15 3.73%
Monthly
8.88%
Yearly
46.83%
Q1 Forecast
3.78

Acasti Pharma reported $-3.18M in EBITDA for its fiscal quarter ending in March of 2025.





Ebitda Change Date
Acasti Pharma USD -3.18M 521K Mar/2025
Addus HomeCare USD 50.34M 5.19M Dec/2025
Amarin USD 12.54M 28.57M Jun/2025
Cassava Sciences USD -11.73M 33.44M Sep/2025
Knight Therapeutics CAD 15.51M 3.39M Jun/2025
Option Care Health USD 126M 6.5M Dec/2025
Organigram Holdings CAD 6.15M 455K Sep/2025
Tilray USD 8.36M 1.82M Sep/2025